| 24/12/2018 | Change of Director’s Interest Notice – RD |
| 24/12/2018 | Change of Director’s Interest Notice – MJ |
| 24/12/2018 | Change of Director’s Interest Notice – EK |
| 24/12/2018 | Change of Director’s Interest Notice – BS |
| 21/12/2018 | Share Purchase Plan Results |
| 14/12/2018 | Results of Annual General Meeting |
| 30/11/2018 | Rhinomed Appoints CFO, Consolidates Australian Distribution |
| 22/11/2018 | Revised Indicative Timetable – Share Purchase Plan |
| 21/11/2018 | Share Purchase Plan – Offer Document |
| 14/11/2018 | Notice of Annual General Meeting: Proxy Form |
| 07/11/2018 | Change of Director’s Interest Notice – RD |
| 02/11/2018 | Rhinomed Completes A$5.0 Million Capital Raise |
| 02/11/2018 | Extension of Time to Hold AGM Granted by ASIC |
| 31/10/2018 | Market Announcement: Trading Halt |
| 15/10/2018 | Notice of Change of Interests of Substantial Holder – WG |
| 02/10/2018 | US Medical Cannabis Licensing Deal – Investor Call |
| 01/10/2018 | Rhinomed Signs 12-Year Medical Cannabis Licensing Deal |
| 27/09/2018 | Corporate Governance Statement 2018 |
| 19/09/2018 | Rhinomed Reports Strong Progress on Multiple Fronts |
| 31/08/2018 | Notice of Change of Interests of Substantial Holder – Dr. JMcB |
| 02/07/2018 | Notice of Change of Interests of Substantial Holder – TFC Pty Ltd |
| 26/06/2018 | Notice of Change of Interests of Substantial Holder – WG |
| 21/06/2018 | RNO and US-Based Columbia Care to Develop Cannabis Based Medicines |
| 21/06/2018 | Market Announcement: Trading Halt |
| 19/06/2018 | Mute Expands Ranging in Leading US Pharmacy – Over 1100 New Stores |
| 28/05/2018 | New Retailer to Stock Mute in 3000 New Pharmacies Across US |
| 07/05/2018 | Trial of Mute in GNC Ends |
| 02/05/2018 | Notice of Change of Interests of Substantial Holder – PS & ES |
| 29/03/2018 | Becoming a Substantial Holder – TFC Pty Ltd |
| 22/03/2018 | Change of Director’s Interest Notice – RD |
| 22/03/2018 | Change of Director’s Interest Notice – MJ |
| 06/03/2018 | Becoming a Substantial Holder – PS & ES |
| 05/03/2018 | Rhinomed Attendance at International Investor Conferences |
| 02/03/2018 | Change in Executive Remuneration |
| 22/02/2018 | Results of General Meeting |
| 05/02/2018 | Rhinomed Expands US Distribution with Major American Healthcare Company |
